A NIR fluorescent smart probe for imaging tumor hypoxia
Abstract
Abstract Background Tumor hypoxia is a characteristic of paramount importance due to low oxygenation levels in tissue negatively correlating with resistance to traditional therapies. The ability to noninvasively identify such could provide for personalized treatment(s) and enhance survival rates. Accordingly, we recently developed an NIR fluorescent hypoxia‐sensitive smart probe ( NO 2 ‐Rosol ) for identifying hypoxia via selectively imaging nitroreductase (NTR) activity, which could correlate to oxygen deprivation levels in cells, thereby serving as a proxy. We demonstrated proof of concept by subjecting a glioblastoma (GBM) cell line to extreme stress by evaluating such under radiobiological hypoxic ( p O 2 ≤ ~0.5%) conditions, which is a far cry from representative levels for hypoxia for brain glioma ( p O 2 = ~1.7%) which fluctuate little from physiological hypoxic ( p O 2 = 1.0‐3.0%) conditions. Aim We aimed to evaluate the robustness, suitability, and feasibility of NO 2 ‐Rosol for imaging hypoxia in vitro and in vivo via assessing NTR activity in diverse GBM models under relevant oxygenation levels ( p O 2 = 2.0%) within physiological hypoxic conditions that mimic oxygenation levels in GBM tumor tissue in the brain. Methods We evaluated multiple GBM cell lines tomore »
- Authors:
-
- Department of Radiology Stanford University School of Medicine Stanford California USA, Department of Otolaryngology ‐ Head &, Neck Surgery Stanford University Stanford California USA
- Department of Radiology Stanford University School of Medicine Stanford California USA
- Department of Radiation Oncology Stanford University School of Medicine Stanford California USA
- Publication Date:
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1773937
- Alternate Identifier(s):
- OSTI ID: 1786146
- Grant/Contract Number:
- DOE DE‐SC0008397
- Resource Type:
- Published Article
- Journal Name:
- Cancer Reports
- Additional Journal Information:
- Journal Name: Cancer Reports Journal Volume: 4 Journal Issue: 5; Journal ID: ISSN 2573-8348
- Publisher:
- Wiley Blackwell (John Wiley & Sons)
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Citation Formats
Hettie, Kenneth S., Klockow, Jessica L., Moon, Eui Jung, Giaccia, Amato J., and Chin, Frederick T. A NIR fluorescent smart probe for imaging tumor hypoxia. Country unknown/Code not available: N. p., 2021.
Web. doi:10.1002/cnr2.1384.
Hettie, Kenneth S., Klockow, Jessica L., Moon, Eui Jung, Giaccia, Amato J., & Chin, Frederick T. A NIR fluorescent smart probe for imaging tumor hypoxia. Country unknown/Code not available. https://doi.org/10.1002/cnr2.1384
Hettie, Kenneth S., Klockow, Jessica L., Moon, Eui Jung, Giaccia, Amato J., and Chin, Frederick T. Sat .
"A NIR fluorescent smart probe for imaging tumor hypoxia". Country unknown/Code not available. https://doi.org/10.1002/cnr2.1384.
@article{osti_1773937,
title = {A NIR fluorescent smart probe for imaging tumor hypoxia},
author = {Hettie, Kenneth S. and Klockow, Jessica L. and Moon, Eui Jung and Giaccia, Amato J. and Chin, Frederick T.},
abstractNote = {Abstract Background Tumor hypoxia is a characteristic of paramount importance due to low oxygenation levels in tissue negatively correlating with resistance to traditional therapies. The ability to noninvasively identify such could provide for personalized treatment(s) and enhance survival rates. Accordingly, we recently developed an NIR fluorescent hypoxia‐sensitive smart probe ( NO 2 ‐Rosol ) for identifying hypoxia via selectively imaging nitroreductase (NTR) activity, which could correlate to oxygen deprivation levels in cells, thereby serving as a proxy. We demonstrated proof of concept by subjecting a glioblastoma (GBM) cell line to extreme stress by evaluating such under radiobiological hypoxic ( p O 2 ≤ ~0.5%) conditions, which is a far cry from representative levels for hypoxia for brain glioma ( p O 2 = ~1.7%) which fluctuate little from physiological hypoxic ( p O 2 = 1.0‐3.0%) conditions. Aim We aimed to evaluate the robustness, suitability, and feasibility of NO 2 ‐Rosol for imaging hypoxia in vitro and in vivo via assessing NTR activity in diverse GBM models under relevant oxygenation levels ( p O 2 = 2.0%) within physiological hypoxic conditions that mimic oxygenation levels in GBM tumor tissue in the brain. Methods We evaluated multiple GBM cell lines to determine their relative sensitivity to oxygenation levels via measuring carbonic anhydrase IX (CAIX) levels, which is a surrogate marker for indirectly identifying hypoxia by reporting on oxygen deprivation levels and upregulated NTR activity. We evaluated for hypoxia via measuring NTR activity when employing NO 2 ‐Rosol in in vitro and tumor hypoxia imaging studies in vivo. Results The GBM39 cell line demonstrated the highest CAIX expression under hypoxic conditions representing that of GBM in the brain. NO 2 ‐Rosol displayed an 8‐fold fluorescence enhancement when evaluated in GBM39 cells ( p O 2 = 2.0%), thereby establishing its robustness and suitability for imaging hypoxia under relevant physiological conditions. We demonstrated the feasibility of NO 2 ‐Rosol to afford tumor hypoxia imaging in vivo via it demonstrating a tumor‐to‐background of 5 upon (i) diffusion throughout, (ii) bioreductive activation by NTR activity in, and (iii) retention within, GBM39 tumor tissue. Conclusion We established the robustness, suitability, and feasibility of NO 2 ‐Rosol for imaging hypoxia under relevant oxygenation levels in vitro and in vivo via assessing NTR activity in GBM39 models.},
doi = {10.1002/cnr2.1384},
journal = {Cancer Reports},
number = 5,
volume = 4,
place = {Country unknown/Code not available},
year = {Sat Apr 03 00:00:00 EDT 2021},
month = {Sat Apr 03 00:00:00 EDT 2021}
}
https://doi.org/10.1002/cnr2.1384
Works referenced in this record:
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors
journal, April 2003
- Sorger, Dietlind; Patt, Marianne; Kumar, Piyush
- Nuclear Medicine and Biology, Vol. 30, Issue 3
Imaging Tumor Hypoxia to Advance Radiation Oncology
journal, July 2014
- Lee, Chen-Ting; Boss, Mary-Keara; Dewhirst, Mark W.
- Antioxidants & Redox Signaling, Vol. 21, Issue 2
Reduction of polynitroaromatic compounds: the bacterial nitroreductases
journal, May 2008
- Roldán, María Dolores; Pérez-Reinado, Eva; Castillo, Francisco
- FEMS Microbiology Reviews, Vol. 32, Issue 3
Progress toward overcoming hypoxia-induced resistance to solid tumor therapy
journal, August 2015
- Reginato, Mauricio; Karakashev, Sergey
- Cancer Management and Research
18F-Fluoromisonidazole in tumor hypoxia imaging
journal, October 2017
- Xu, Zuoyu; Li, Xiao-Feng; Zou, Hongyan
- Oncotarget, Vol. 8, Issue 55
Ultrasensitive Near-Infrared Fluorescence-Enhanced Probe for in Vivo Nitroreductase Imaging
journal, May 2015
- Li, Yuhao; Sun, Yun; Li, Jiachang
- Journal of the American Chemical Society, Vol. 137, Issue 19
The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in Radiotherapy
journal, December 1953
- Gray, L. H.; Conger, A. D.; Ebert, M.
- The British Journal of Radiology, Vol. 26, Issue 312
Cell cycle progression in glioblastoma cells is unaffected by pathophysiological levels of hypoxia
journal, January 2016
- Richards, Rosalie; Jenkinson, Michael D.; Haylock, Brian J.
- PeerJ, Vol. 4
Molecular Imaging of Hypoxia: Strategies for Probe Design and Application
journal, August 2011
- Apte, Sandeep; T. Chin, Frederick; E. Graves, Edward
- Current Organic Synthesis, Vol. 8, Issue 4
Two-photon fluorescent probe for detection of nitroreductase and hypoxia-specific microenvironment of cancer stem cell
journal, September 2018
- Liu, Yajing; Liu, Wei; Li, Hongjuan
- Analytica Chimica Acta, Vol. 1024
Function of carbonic anhydrase IX in glioblastoma multiforme
journal, October 2012
- Proescholdt, M. A.; Merrill, M. J.; Stoerr, E. -M.
- Neuro-Oncology, Vol. 14, Issue 11
Hypoxia: Signaling the Metastatic Cascade
journal, June 2016
- Rankin, Erinn B.; Nam, Jin-Min; Giaccia, Amato J.
- Trends in Cancer, Vol. 2, Issue 6
A novel off-on fluorescent probe for imaging of hypoxia in tumor cell
journal, February 2018
- Wei, Chen; Shen, Yuanzhi; Xu, Zhiqiang
- Journal of Photochemistry and Photobiology A: Chemistry, Vol. 353
The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
journal, October 2014
- Walsh, Joseph C.; Lebedev, Artem; Aten, Edward
- Antioxidants & Redox Signaling, Vol. 21, Issue 10
Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients
journal, September 2003
- Závada, J.; Závadová, Z.; Zat'ovičová, M.
- British Journal of Cancer, Vol. 89, Issue 6
Turn-On Near-Infrared Fluorescent Sensor for Selectively Imaging Serotonin
journal, October 2015
- Hettie, Kenneth S.; Glass, Timothy E.
- ACS Chemical Neuroscience, Vol. 7, Issue 1
Acute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences
journal, March 2012
- Bayer, C.; Vaupel, P.
- Strahlentherapie und Onkologie, Vol. 188, Issue 7
F-18 Fluoromisonidazole for Imaging Tumor Hypoxia: Imaging the Microenvironment for Personalized Cancer Therapy
journal, March 2015
- Rajendran, Joseph G.; Krohn, Kenneth A.
- Seminars in Nuclear Medicine, Vol. 45, Issue 2
A novel off–on fluorescent probe for sensitive imaging of mitochondria-specific nitroreductase activity in living tumor cells
journal, January 2017
- Huang, Bo; Chen, Wen; Kuang, Yong-Qing
- Organic & Biomolecular Chemistry, Vol. 15, Issue 20
Near-Infrared Fluorescent Rosol Dye Tailored toward Lymphatic Mapping Applications
journal, January 2019
- Hettie, Kenneth S.; Klockow, Jessica L.; Glass, Timothy E.
- Analytical Chemistry, Vol. 91, Issue 4
The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
journal, May 2019
- Pastorekova, Silvia; Gillies, Robert J.
- Cancer and Metastasis Reviews, Vol. 38, Issue 1-2
A new fluorescent probe with a large turn-on signal for imaging nitroreductase in tumor cells and tissues by two-photon microscopy
journal, March 2017
- Liu, Zhan-Rong; Tang, Yonghe; Xu, An
- Biosensors and Bioelectronics, Vol. 89
Targeted Myocardial Hypoxia Imaging Using a Nitroreductase-Activatable Near-Infrared Fluorescent Nanoprobe
journal, April 2019
- Fan, Yunshi; Lu, Mi; Yu, Xie-an
- Analytical Chemistry, Vol. 91, Issue 10
Synthesis and characterization of new rhodamine dyes with large Stokes shift
journal, December 2013
- Tian, Zhidan; Tian, Baozhu; Zhang, Jinlong
- Dyes and Pigments, Vol. 99, Issue 3
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
journal, February 2001
- Hockel, M.; Vaupel, P.
- JNCI Journal of the National Cancer Institute, Vol. 93, Issue 4
Imaging tumour hypoxia with positron emission tomography
journal, December 2014
- Fleming, I. N.; Manavaki, R.; Blower, P. J.
- British Journal of Cancer, Vol. 112, Issue 2
Hypoxia-Sensitive Fluorescent Probes for in Vivo Real-Time Fluorescence Imaging of Acute Ischemia
journal, November 2010
- Kiyose, Kazuki; Hanaoka, Kenjiro; Oushiki, Daihi
- Journal of the American Chemical Society, Vol. 132, Issue 45
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
journal, March 2014
- McKeown, S. R.
- The British Journal of Radiology, Vol. 87, Issue 1035
Multifunctional Probe Based on Cationic Conjugated Polymers for Nitroreductase-Related Analysis: Sensing, Hypoxia Diagnosis, and Imaging
journal, April 2017
- Zhang, Xiaoqian; Zhao, Qi; Li, Yanru
- Analytical Chemistry, Vol. 89, Issue 10
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
journal, August 2003
- Shannon, Aoife M.; Bouchier-Hayes, David J.; Condron, Claire M.
- Cancer Treatment Reviews, Vol. 29, Issue 4
A biotinylated piperazine-rhodol derivative: a ‘turn-on’ probe for nitroreductase triggered hypoxia imaging
journal, January 2017
- Zhou, Ying; Bobba, Kondapa Naidu; Lv, Xue Wei
- The Analyst, Vol. 142, Issue 2
Efficient Two-Photon Fluorescent Probe for Nitroreductase Detection and Hypoxia Imaging in Tumor Cells and Tissues
journal, November 2015
- Zhang, Jing; Liu, Hong-Wen; Hu, Xiao-Xiao
- Analytical Chemistry, Vol. 87, Issue 23
Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
journal, May 2009
- Rockwell, Sara; Dobrucki, Iwona; Kim, Eugene
- Current Molecular Medicine, Vol. 9, Issue 4
Hypoxia and metabolic adaptation of cancer cells
journal, January 2016
- Eales, K. L.; Hollinshead, K. E. R.; Tennant, D. A.
- Oncogenesis, Vol. 5, Issue 1
Expression of MaTu-MN protein in human tumor cultures and in clinical specimens
journal, May 1993
- Závada, J.; Závadová, Z.; Pastoreková, S.
- International Journal of Cancer, Vol. 54, Issue 2
Detection and Characterization of Tumor Hypoxia Using pO 2 Histography
journal, August 2007
- Vaupel, Peter; Höckel, Michael; Mayer, Arnulf
- Antioxidants & Redox Signaling, Vol. 9, Issue 8
An activatable NIR fluorescent rosol for selectively imaging nitroreductase activity
journal, March 2020
- Klockow, Jessica L.; Hettie, Kenneth S.; LaGory, Edward L.
- Sensors and Actuators B: Chemical, Vol. 306
The synthesis and characterization of novel coumarin dyes derived from 1,4-diethyl-1,2,3,4-tetrahydro-7-hydroxyquinoxalin-6-carboxaldehyde
journal, July 2009
- Jagtap, Amit R.; Satam, Vijay S.; Rajule, Rajkumar N.
- Dyes and Pigments, Vol. 82, Issue 1